Login / Signup

Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.

Yi-Chan LeeTa-Jen LeeNgan-Ming TsangYenlin HuangCheng-Lung HsuLi-Jen HsinYi-Hsuan LeeKai-Ping Chang
Published in: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale (2018)
Because maxillary adenoid cystic carcinoma is associated with a higher rate of cavernous sinus invasion, such cases warrant caution during preoperative planning. Primary surgery as the initial therapy provides better locoregional control and survival for patients with sinonasal adenoid cystic carcinoma. Cavernous sinus invasion did not significantly impact survival; thus, it should not be regarded as a contraindication for curative treatment.
Keyphrases
  • cell migration
  • minimally invasive
  • patients undergoing
  • free survival
  • coronary artery bypass
  • stem cells
  • coronary artery disease
  • combination therapy
  • acute coronary syndrome
  • surgical site infection